OpenAI is barreling toward what could be one of the largest tech IPOs in history. But the road to Wall Street is getting bumpy, and most of the potholes have Sam Altman’s name on them.

Republican attorneys general from multiple states are now investigating the CEO’s potential conflicts of interest as the company prepares to go public. The House Oversight Committee has also entered the chat, seeking detailed information about OpenAI’s governance practices and whether fiduciary responsibilities are being met. For a company with a speculative valuation reaching $850 billion, that’s a lot of political heat at the worst possible time.

The conflict of interest question

Here’s the thing. The core concern revolves around Altman’s personal investment portfolio and how it overlaps with OpenAI’s business decisions. Investigators are questioning whether proper disclosures were made regarding Altman’s financial ties to companies that OpenAI has considered investing in, including Helion Energy and Stoke Space.

In English: when the CEO of a company personally invests in firms that his company might also invest in, regulators tend to get curious. And “curious” is a polite word for what’s happening here.

The scrutiny isn’t coming from one direction, either. Multiple state-level Republican AGs are running parallel inquiries, and Congress is layering its own investigation on top. That kind of bipartisan-adjacent pressure, where both legislative and state-level officials are circling the same target, rarely ends with a handshake and a press release.

Adding fuel to the governance bonfire, OpenAI president Greg Brockman disclosed during a trial that his equity stake in the company is valued at nearly $30 billion. That revelation has raised its own set of questions about independence from Altman and whether the leadership structure concentrates too much financial power in too few hands.

A governance overhaul that may not be enough

This isn’t OpenAI’s first dance with governance drama. After Altman was temporarily ousted by the board in November 2023, in a saga that played out like a tech-world season finale nobody asked for, the company revamped its board structure. The goal was to address the exact kind of fiduciary conflicts and governance gaps that are now under investigation again.

The board shakeup was supposed to be the fix. New directors, clearer oversight mechanisms, a fresh start. But the current wave of scrutiny suggests those reforms either didn’t go far enough or haven’t been implemented with enough teeth. When the same governance concerns resurface within roughly a year of a major restructuring, it raises a natural question: was the overhaul cosmetic or structural?

Look, OpenAI’s transition from a nonprofit research lab to a for-profit juggernaut was always going to create friction. The original mission, building artificial general intelligence that benefits humanity, doesn’t slot neatly into the incentive structures of a company preparing for a public listing. That tension has been simmering for years. The IPO just turned up the temperature.

The company’s infrastructure ambitions are enormous, with investment needs for AI infrastructure totaling around $1.4 trillion. That kind of capital requirement makes a public offering not just attractive but arguably necessary. Which means governance issues aren’t just a PR headache. They’re a potential deal risk.

What this means for investors and the broader market

An $850 billion valuation would make OpenAI one of the most valuable companies to ever go public. For context, that figure would place it in the neighborhood of some of the largest publicly traded companies on Earth. It would dwarf the IPO valuations of Meta, Google, and pretty much every other tech company that’s ever rung the bell at the New York Stock Exchange.

But valuations that enormous come with proportionally enormous expectations around corporate governance. Public market investors, particularly institutional ones, tend to care deeply about board independence, conflict-of-interest policies, and CEO accountability. The SEC has its own set of requirements for public companies, and the kind of questions being asked by Congress and state attorneys general right now are exactly the kind that securities regulators pay attention to during the IPO process.

For the crypto market, the stakes are indirect but real. AI-related tokens have traded in loose correlation with sentiment around major AI companies, particularly OpenAI and its competitors. Any sustained disruption to OpenAI’s leadership, governance structure, or IPO timeline could ripple through market perceptions of the entire AI sector, including the blockchain-adjacent corners of it.

The competitive landscape matters here too. OpenAI is facing rising competition from Google’s Gemini, Anthropic’s Claude, Meta’s Llama models, and a growing roster of open-source alternatives. Internal strife and political investigations don’t exactly help a company stay nimble while its rivals are moving fast. If governance distractions slow down OpenAI’s product roadmap or spook potential investors, competitors are more than happy to absorb the attention and the capital.

What to watch: the timeline and outcome of the state AG investigations, any formal SEC commentary on OpenAI’s IPO filing when it materializes, and whether the House Oversight Committee’s inquiry produces subpoenas or stays at the information-request level. The difference between a Congressional letter and a Congressional subpoena is roughly the difference between a warning light and a fire alarm. Right now, the warning light is on.